| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Biotechnology
| Moderna is making significant advancements in product development, particularly in cancer vaccine and treatment research, indicating a strong focus on innovation in the medical field. Positive results from clinical trials, especially in personalized cancer vaccines, have raised hopes for effective therapies. However, concerns over the reliability and efficacy of their melanoma vaccine, coupled with negative market reactions to leaked data, pose challenges for the company's reputation and investor confidence. The balance between promising clinical outcomes and ongoing skepticism reflects the complexities of product development in the pharmaceutical industry. |
| The price action of Moderna Inc (MRNA) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -2.4 is extremely bearish. The market sentiment at -0.9 is bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. MRNA is likely to move down since both trend sentiment and market sentiment are negative. The positive sentiment force for sector is at 0.3, and the negative at -1.2 on 2026-10-26. The forces of Stock Price Trend (-2.4), Sentiment towards Fundamentals (-1.9), Valuation Sentiment (-1.5), and Market Risk Appetite (-1.4) will drive down the price. The forces of Price Level Sentiment (0), Sector Price Trend (0.2), and Option Sentiment (1.5) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| MRNA | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-26 | 0%(0.4%) | 199.03 | 9.01% | 36 | 49 | 46 | -0.34% | -1.12% | -2.4 | 0.6 | 1.9% | -0.9 | Short | 65% | -1.9 | -1.7 |
| 2026-10-25 | 0%(0.4%) | -0.4 | 0.6 | -0.3 | -0.8 | -1 | ||||||||||
| 2026-10-24 | 1%(0.4%) | -0.4 | 0.6 | -0.2 | -0.5 | -5.5 | ||||||||||
| 2026-10-23 | 1%(0.3%) | 199.7 | 8.99% | 37 | 52 | 31 | -1.15% | 0.18% | -0.4 | -1.4 | 10.8% | 0.4 | Short | 55% | 0.5 | -2.8 |
| 2026-10-22 | 1%(0.1%) | 202.03 | 8.96% | 41 | 53 | 26 | -18.38% | 0.27% | -0.7 | -5.1 | 11% | 0.6 | Short | 55% | 1 | -7.7 |
| 2026-10-21 | 0%(0%) | 247.53 | 7.66% | 102 | 67 | 71 | 2.73% | 2.82% | 5.7 | 0.6 | 3.5% | 1.9 | Long | 70% | 3.2 | 7 |
| 2026-10-20 | 0%(0%) | 240.96 | 7.52% | 101 | 62 | 74 | 6.41% | 1.79% | 5.2 | 1.9 | 3.7% | 1.1 | Long | 60% | 3.1 | -1 |
| 2026-10-19 | 0%(0%) | 226.44 | 8.51% | 85 | 59 | 69 | 4.96% | 1.73% | 3.5 | 0.3 | 3.9% | 1 | Long | 65% | 3.5 | 6 |
| 2026-10-18 | 0%(0%) | 4 | 0.3 | 0.5 | 2.1 | 6 | ||||||||||
| 2026-10-17 | 0%(0%) | 4 | 0.3 | 0.6 | 1.6 | -1 | ||||||||||
| Short is the preferred trading strategy with 65% chance of being right. Both trend sentiment and hourly trend are very weak. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| 2026-10-26 22:47:06 Emphasis on the CEO's response to the challenges faced by the company regarding the cancer vaccine. |
| 2026-10-26 22:47:06 Discussion on the negative impact of data leaks on Moderna’s stock performance. |
| 2026-10-26 22:47:06 Focus on the advancements in cancer vaccine development, highlighting the collaboration between Moderna and Merck. |
| 2026-10-26 17:15:21 Concerns over public and investor perception due to challenges faced in vaccine trials. |
| 2026-10-26 17:15:21 The market's reaction to leaked trial data revealing less favorable outcomes than anticipated. |
| 2026-10-26 17:15:21 Discussion around the ongoing development of Moderna's cancer vaccine, highlighting both progress and setbacks. |
| 2026-10-26 17:15:21 Stocks of Moderna have seen fluctuations, with the latest reports indicating a slight decline. |
| 2026-10-26 17:15:21 The articles reflect a decline in investor confidence surrounding Moderna's cancer vaccine despite initial high expectations. |
| 2026-10-26 13:47:42 The data leak raises concerns about transparency and regulation within the biotech industry, potentially affecting investor trust. |
| 2026-10-26 13:47:42 The involvement of a social media influencer illustrates the growing trend of social media affecting perception and value in the stock market. |
| 2026-10-26 13:47:42 The article discusses the dramatic fluctuations in Moderna's stock due to a data leak and external commentary, highlighting the volatile nature of stock performance. |
| 2026-10-26 11:48:11 Addresses the cooling excitement in the stock market regarding Moderna's cancer vaccine and its impact on stock performance. |
| 2026-10-26 11:48:11 Focuses on the experimental nature of Moderna's cancer vaccine and the challenges faced in the development process. |
| 2026-10-26 11:48:11 The article discusses how high investor expectations around Moderna's cancer vaccine are being tempered by the results of Phase 3 data. |